Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 15, 2026

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform
05:51

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform

Published on: May 3, 2024

Scaleable purification process for gene therapy retroviral vectors.

Teresa Rodrigues1, Andreia Carvalho, Marlene Carmo

  • 1ITQB/IBET, Av. da República (EAN), P-2781-901 Oeiras, Portugal.

The Journal of Gene Medicine
|April 13, 2007
PubMed
Summary

A new purification process using membrane separation and anion-exchange chromatography (AEXc) effectively purifies retroviral vectors (RVs). This scalable method yields highly pure, potent RVs suitable for gene therapy applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shaping cell therapy manufacturing with metabolic understanding and control.

Trends in biotechnology·2026
Same author

Ferritin nanoparticles displaying rift valley fever virus glycoprotein elicit potent dendritic cell activation in vitro.

Virology journal·2026
Same author

Bridging process diversity in cell therapies toward standardization of manufacturing workflows.

Cytotherapy·2026
Same author

3D co-cultures of primary human hepatocytes and Kupffer-like cells to address innate immune responses to rAAV.

Scientific reports·2025
Same author

Site-directed tyrosinase conjugation on engineered ferritin retains immune recognition.

Scientific reports·2025
Same author

Engineering a Perfusion Bioreactor System for hiPSC-Derived Progenitor Co-Culture Capturing Microglial Features in CNS Development.

Biotechnology and bioengineering·2025

Area of Science:

  • Gene Therapy
  • Biotechnology
  • Virology

Background:

  • Retroviral vectors (RVs) are key tools for gene therapy.
  • Developing scalable, mild purification processes is crucial for clinical success.

Purpose of the Study:

  • To develop a scalable purification strategy for murine leukemia virus (MLV)-derived vectors.
  • To achieve high purity, titer, and potency in viral preparations.

Main Methods:

  • Utilized membrane separation (microfiltration and ultrafiltration) for clarification and concentration.
  • Employed anion-exchange chromatography (AEXc) with DEAE functional ligands for purification.
  • Scaled up the process 16-fold to validate its applicability.

Main Results:

More Related Videos

Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

Related Experiment Videos

Last Updated: Jul 15, 2026

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform
05:51

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform

Published on: May 3, 2024

Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

  • Achieved nearly 100% recovery of infectious particles during membrane separation.
  • AEXc purification removed protein contaminants, yielding 77%±11% recovery of infectious vectors.
  • The scaled-up process produced high-titer (3.2x10^8 IP/ml) and >99% pure vectors with enhanced transduction efficiency.

Conclusions:

  • A combined membrane separation and AEXc process is a feasible and scalable purification strategy for MLV-derived vectors.
  • This method effectively removes inhibitory contaminants, producing pure vectors with improved transduction efficiencies.